After coming to market as a game changer the Johnson and Johnson vaccine which only requires one dose has been paused over blood clot concerns similar to their counterpart AstraZeneca. While this looks to be a temporary hiccup, this could slow the path towards herd immunity.
Plus the top stories of the week and the top ten dangers of digital health.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More